Exploratory Study of the Effects of Peptide PMS-001 on Long-Delay Recall in Patients With Moderate to Severe Dementia
NCT06946511
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Dementia
Interventions
DRUG:
Peptide PMS-001 Intravenous Injection
DRUG:
Placebo
Sponsor
Ruijin Hospital